Abstract
Several lines of research point to the involvement of aberrant serotonin pathways in autism (e.g., hyperserotonemia and, as recently reported, the doubling of autism risk in children whose mothers took selective serotonin reuptake inhibitors [SSRIs] during the first trimester [JW Psychiatry Aug 29 2011]). To examine this issue further, researchers exposed rats prenatally and postnatally (postnatal …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
